Plutella xylostella chromosome 9, ilPluXylo3.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Yponomeutoidea; Plutellidae; Plutella.
REFSEQ INFORMATION: The reference sequence is identical to\nOW026558.1.\nAssembly name: ilPluXylo3.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/03/10. The original whole-genome shotgun project has the\naccession CAKNZZ000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Plutella xylostella Annotation\n Release 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
small cysteine and glycine repeat-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
acetylcholine receptor subunit alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 265 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
zinc finger protein 1, transcript variant X4
zinc finger protein 1, transcript variant X3
zinc finger protein 1, transcript variant X2
zinc finger protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cytoplasmic dynein 1 intermediate chain, transcript variant X3
cytoplasmic dynein 1 intermediate chain, transcript variant X2
cytoplasmic dynein 1 intermediate chain, transcript variant X6
cytoplasmic dynein 1 intermediate chain, transcript variant X1
cytoplasmic dynein 1 intermediate chain, transcript variant X4
cytoplasmic dynein 1 intermediate chain, transcript variant X7
cytoplasmic dynein 1 intermediate chain, transcript variant X12
cytoplasmic dynein 1 intermediate chain, transcript variant X5
cytoplasmic dynein 1 intermediate chain, transcript variant X10
cytoplasmic dynein 1 intermediate chain, transcript variant X14
cytoplasmic dynein 1 intermediate chain, transcript variant X19
cytoplasmic dynein 1 intermediate chain, transcript variant X8
cytoplasmic dynein 1 intermediate chain, transcript variant X11
cytoplasmic dynein 1 intermediate chain, transcript variant X16
cytoplasmic dynein 1 intermediate chain, transcript variant X9
cytoplasmic dynein 1 intermediate chain, transcript variant X15
cytoplasmic dynein 1 intermediate chain, transcript variant X17
cytoplasmic dynein 1 intermediate chain, transcript variant X20
cytoplasmic dynein 1 intermediate chain, transcript variant X13
cytoplasmic dynein 1 intermediate chain, transcript variant X18
cytoplasmic dynein 1 intermediate chain isoform X6
cytoplasmic dynein 1 intermediate chain isoform X10
cytoplasmic dynein 1 intermediate chain isoform X14
cytoplasmic dynein 1 intermediate chain isoform X19
cytoplasmic dynein 1 intermediate chain isoform X1
cytoplasmic dynein 1 intermediate chain isoform X3
cytoplasmic dynein 1 intermediate chain isoform X2
cytoplasmic dynein 1 intermediate chain isoform X4
cytoplasmic dynein 1 intermediate chain isoform X7
cytoplasmic dynein 1 intermediate chain isoform X12
cytoplasmic dynein 1 intermediate chain isoform X5
cytoplasmic dynein 1 intermediate chain isoform X8
cytoplasmic dynein 1 intermediate chain isoform X11
cytoplasmic dynein 1 intermediate chain isoform X16
cytoplasmic dynein 1 intermediate chain isoform X9
cytoplasmic dynein 1 intermediate chain isoform X15
cytoplasmic dynein 1 intermediate chain isoform X17
cytoplasmic dynein 1 intermediate chain isoform X20
cytoplasmic dynein 1 intermediate chain isoform X13
cytoplasmic dynein 1 intermediate chain isoform X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 155 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
moesin/ezrin/radixin homolog 1, transcript variant X2
moesin/ezrin/radixin homolog 1 isoform X2
moesin/ezrin/radixin homolog 1, transcript variant X1
moesin/ezrin/radixin homolog 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial
MKI67 FHA domain-interacting nucleolar phosphoprotein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 84 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
uncharacterized LOC119691546, transcript variant X2
uncharacterized LOC119691546, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
acetylcholine receptor subunit beta-type unc-29
SAM and SH3 domain-containing protein 1, transcript variant X4
SAM and SH3 domain-containing protein 1, transcript variant X2
SAM and SH3 domain-containing protein 1, transcript variant X6
SAM and SH3 domain-containing protein 1, transcript variant X5
SAM and SH3 domain-containing protein 1, transcript variant X3
SAM and SH3 domain-containing protein 1, transcript variant X1
uncharacterized protein LOC105381380 isoform X4
uncharacterized protein LOC105381380 isoform X2
uncharacterized protein LOC105381380 isoform X6
SAM and SH3 domain-containing protein 1 isoform X5
uncharacterized protein LOC105381380 isoform X3
uncharacterized protein LOC105381380 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
uncharacterized LOC105388638, transcript variant X1
uncharacterized LOC105388638, transcript variant X2
uncharacterized LOC105388638, transcript variant X3
uncharacterized protein LOC105388638 isoform X1
uncharacterized protein LOC105388638 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methionine aminopeptidase 1, transcript variant X3
methionine aminopeptidase 1, transcript variant X2
methionine aminopeptidase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119692986, transcript variant X2
uncharacterized LOC119692986, transcript variant X3
uncharacterized LOC119692986, transcript variant X1
uncharacterized LOC119692986, transcript variant X4
uncharacterized protein LOC119692986 isoform X1
uncharacterized protein LOC119692986 isoform X2
uncharacterized protein LOC119692986 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
mannosyl-oligosaccharide alpha-1,2-mannosidase IA
uncharacterized LOC119690330, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC119690330, transcript variant X3
uncharacterized LOC119690330, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC119690330 isoform X1
uncharacterized protein LOC119690330 isoform X2
uncharacterized LOC105389135, transcript variant X3
uncharacterized LOC105389135, transcript variant X4
uncharacterized LOC105389135, transcript variant X2
uncharacterized LOC105389135, transcript variant X1
uncharacterized protein LOC105389135 isoform X2
uncharacterized protein LOC105389135 isoform X3
uncharacterized protein LOC105389135 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105384482, transcript variant X1
uncharacterized LOC105384482, transcript variant X3
uncharacterized LOC105384482, transcript variant X4
uncharacterized LOC105384482, transcript variant X2
uncharacterized protein LOC105384482 isoform X1
uncharacterized protein LOC105384482 isoform X2
uncharacterized protein LOC105384482 isoform X3
uncharacterized LOC125489023, transcript variant X2
uncharacterized LOC125489023, transcript variant X5
uncharacterized LOC125489023, transcript variant X4
uncharacterized LOC125489023, transcript variant X3
uncharacterized LOC125489023, transcript variant X1
uncharacterized protein LOC125489023 isoform X2
uncharacterized protein LOC125489023 isoform X5
uncharacterized protein LOC125489023 isoform X4
uncharacterized protein LOC125489023 isoform X3
uncharacterized protein LOC125489023 isoform X1
transcription initiation factor TFIID subunit 13, transcript variant X2
transcription initiation factor TFIID subunit 13 isoform X2
transcription initiation factor TFIID subunit 13, transcript variant X1
transcription initiation factor TFIID subunit 13 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
alanine--glyoxylate aminotransferase 2-like, transcript variant X2
alanine--glyoxylate aminotransferase 2-like, transcript variant X1
alanine--glyoxylate aminotransferase 2-like
zinc finger SWIM domain-containing protein 8 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
zinc finger SWIM domain-containing protein 8 homolog isoform X3
zinc finger SWIM domain-containing protein 8 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger SWIM domain-containing protein 8 homolog, transcript variant X2
zinc finger SWIM domain-containing protein 8 homolog isoform X1
zinc finger SWIM domain-containing protein 8 homolog isoform X2
probable E3 ubiquitin-protein ligase HERC4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC105384464 isoform X6
leucine-rich repeat extensin-like protein 2 isoform X1
short neuropeptide F, transcript variant X2
short neuropeptide F, transcript variant X1
uncharacterized LOC125489026, transcript variant X2
uncharacterized LOC125489026, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
intermembrane lipid transfer protein Vps13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
forkhead box protein O, transcript variant X1
forkhead box protein O, transcript variant X2
forkhead box protein O, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
SKI family transcriptional corepressor 2, transcript variant X1
SKI family transcriptional corepressor 2, transcript variant X2
uncharacterized protein LOC105394118 isoform X2
SKI family transcriptional corepressor 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X4
calcium-activated potassium channel slowpoke, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X7
calcium-activated potassium channel slowpoke, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X15
calcium-activated potassium channel slowpoke, transcript variant X27
calcium-activated potassium channel slowpoke, transcript variant X2
calcium-activated potassium channel slowpoke, transcript variant X3
calcium-activated potassium channel slowpoke, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X26
calcium-activated potassium channel slowpoke, transcript variant X14
calcium-activated potassium channel slowpoke, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X29
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X34
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X9
calcium-activated potassium channel slowpoke, transcript variant X21
calcium-activated potassium channel slowpoke, transcript variant X33
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X37
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X35
calcium-activated potassium channel slowpoke, transcript variant X39
calcium-activated potassium channel slowpoke, transcript variant X40
calcium-activated potassium channel slowpoke, transcript variant X8
calcium-activated potassium channel slowpoke, transcript variant X16
calcium-activated potassium channel slowpoke, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
calcium-activated potassium channel slowpoke, transcript variant X36
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
calcium-activated potassium channel slowpoke isoform X5
calcium-activated potassium channel slowpoke isoform X4
calcium-activated potassium channel slowpoke isoform X1
calcium-activated potassium channel slowpoke isoform X21
calcium-activated potassium channel slowpoke isoform X15
calcium-activated potassium channel slowpoke isoform X27
calcium-activated potassium channel slowpoke isoform X19
calcium-activated potassium channel slowpoke isoform X26
calcium-activated potassium channel slowpoke isoform X22
calcium-activated potassium channel slowpoke isoform X33
calcium-activated potassium channel slowpoke isoform X37
calcium-activated potassium channel slowpoke isoform X14
calcium-activated potassium channel slowpoke isoform X23
calcium-activated potassium channel slowpoke isoform X34
calcium-activated potassium channel slowpoke isoform X38
calcium-activated potassium channel slowpoke isoform X35
calcium-activated potassium channel slowpoke isoform X39
calcium-activated potassium channel slowpoke isoform X40
calcium-activated potassium channel slowpoke isoform X6
calcium-activated potassium channel slowpoke isoform X2
calcium-activated potassium channel slowpoke isoform X25
calcium-activated potassium channel slowpoke isoform X7
calcium-activated potassium channel slowpoke isoform X3
calcium-activated potassium channel slowpoke isoform X13
calcium-activated potassium channel slowpoke isoform X10
calcium-activated potassium channel slowpoke isoform X20
calcium-activated potassium channel slowpoke isoform X18
calcium-activated potassium channel slowpoke isoform X29
calcium-activated potassium channel slowpoke isoform X8
calcium-activated potassium channel slowpoke isoform X16
calcium-activated potassium channel slowpoke isoform X28
calcium-activated potassium channel slowpoke isoform X36
calcium-activated potassium channel slowpoke isoform X31
calcium-activated potassium channel slowpoke isoform X24
calcium-activated potassium channel slowpoke isoform X11
calcium-activated potassium channel slowpoke isoform X32
calcium-activated potassium channel slowpoke isoform X30
calcium-activated potassium channel slowpoke isoform X12
calcium-activated potassium channel slowpoke isoform X9
calcium-activated potassium channel slowpoke isoform X17
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 1 isoform X1
ubiquitin carboxyl-terminal hydrolase 1 isoform X2
ubiquitin carboxyl-terminal hydrolase 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105383085, transcript variant X3
uncharacterized LOC105383085, transcript variant X2
uncharacterized LOC105383085, transcript variant X1
uncharacterized LOC105383085, transcript variant X5
uncharacterized LOC105383085, transcript variant X4
uncharacterized protein LOC105383085 isoform X3
uncharacterized protein LOC105383085 isoform X2
uncharacterized protein LOC105383085 isoform X5
uncharacterized protein LOC105383085 isoform X4
uncharacterized protein LOC105383085 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tachykinin-like peptides receptor 99D, transcript variant X3
tachykinin-like peptides receptor 99D, transcript variant X1
tachykinin-like peptides receptor 99D, transcript variant X2
tachykinin-like peptides receptor 99D isoform X2
tachykinin-like peptides receptor 99D isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
thiamin pyrophosphokinase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
thiamin pyrophosphokinase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
thiamin pyrophosphokinase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
thiamin pyrophosphokinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
thiamin pyrophosphokinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
signal recognition particle 19 kDa protein
tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit wuho
mitotic checkpoint serine/threonine-protein kinase BUB1 beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
rhodanese domain-containing protein CG4456, transcript variant X3
rhodanese domain-containing protein CG4456, transcript variant X4
rhodanese domain-containing protein CG4456, transcript variant X1
rhodanese domain-containing protein CG4456, transcript variant X2
rhodanese domain-containing protein CG4456 isoform X1
rhodanese domain-containing protein CG4456 isoform X2
rhodanese domain-containing protein CG4456 isoform X3
putative thiosulfate sulfurtransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
odorant receptor 4-like, transcript variant X3
odorant receptor 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
odorant receptor 4-like, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 3-like
A disintegrin and metalloproteinase with thrombospondin motifs 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
odorant receptor 67a, transcript variant X2
odorant receptor 67a, transcript variant X1
putative odorant receptor 92a isoform X2
uncharacterized LOC119694106, transcript variant X1
uncharacterized protein LOC119694106 isoform X1
uncharacterized LOC119694106, transcript variant X2
uncharacterized protein LOC119694106 isoform X2
uncharacterized LOC105393123, transcript variant X1
uncharacterized LOC105393123, transcript variant X2
uncharacterized protein LOC105393123 isoform X1
uncharacterized protein LOC105393123 isoform X2
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 10, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 10 isoform X1
disintegrin and metalloproteinase domain-containing protein 10 isoform X2
disintegrin and metalloproteinase domain-containing protein 10 isoform X3
uncharacterized LOC119692054, transcript variant X2
uncharacterized LOC119692054, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC119692054 isoform X2
uncharacterized protein LOC119692054 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
cell division cycle and apoptosis regulator protein 1
putative sodium-dependent multivitamin transporter, transcript variant X1
putative sodium-dependent multivitamin transporter, transcript variant X3
putative sodium-dependent multivitamin transporter, transcript variant X2
putative sodium-dependent multivitamin transporter
uncharacterized LOC105393136, transcript variant X10
uncharacterized LOC105393136, transcript variant X8
uncharacterized LOC105393136, transcript variant X9
uncharacterized LOC105393136, transcript variant X11
uncharacterized LOC105393136, transcript variant X13
uncharacterized LOC105393136, transcript variant X12
uncharacterized LOC105393136, transcript variant X2
uncharacterized LOC105393136, transcript variant X1
uncharacterized LOC105393136, transcript variant X3
uncharacterized LOC105393136, transcript variant X7
uncharacterized LOC105393136, transcript variant X6
uncharacterized LOC105393136, transcript variant X5
uncharacterized LOC105393136, transcript variant X4
uncharacterized LOC105393136, transcript variant X17
uncharacterized LOC105393136, transcript variant X16
uncharacterized LOC105393136, transcript variant X15
uncharacterized LOC105393136, transcript variant X14
uncharacterized protein LOC105393136 isoform X9
uncharacterized protein LOC105393136 isoform X10
uncharacterized protein LOC105393136 isoform X8
uncharacterized protein LOC105393136 isoform X11
uncharacterized protein LOC105393136 isoform X13
uncharacterized protein LOC105393136 isoform X12
uncharacterized protein LOC105393136 isoform X3
uncharacterized protein LOC105393136 isoform X2
uncharacterized protein LOC105393136 isoform X7
uncharacterized protein LOC105393136 isoform X6
uncharacterized protein LOC105393136 isoform X16
uncharacterized protein LOC105393136 isoform X15
uncharacterized protein LOC105393136 isoform X5
uncharacterized protein LOC105393136 isoform X4
uncharacterized protein LOC105393136 isoform X1
uncharacterized protein LOC105393136 isoform X14
uncharacterized LOC119692785, transcript variant X1
uncharacterized LOC119692785, transcript variant X2
uncharacterized protein LOC119692785 isoform X1
uncharacterized protein LOC119692785 isoform X2
ras-related protein Rab-27A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ras-related protein Rab-27A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
tachykinin-like peptides receptor 86C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tachykinin-like peptides receptor 86C, transcript variant X3
tachykinin-like peptides receptor 86C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tachykinin-like peptides receptor 86C isoform X1
tachykinin-like peptides receptor 86C isoform X2
tachykinin-like peptides receptor 86C isoform X3
tyrosine kinase receptor Cad96Ca, transcript variant X1
tyrosine kinase receptor Cad96Ca, transcript variant X4
tyrosine kinase receptor Cad96Ca, transcript variant X2
tyrosine kinase receptor Cad96Ca, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
tyrosine kinase receptor Cad96Ca isoform X1
tyrosine kinase receptor Cad96Ca isoform X4
tyrosine kinase receptor Cad96Ca isoform X2
tyrosine kinase receptor Cad96Ca isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
carbonic anhydrase 1, transcript variant X1
carbonic anhydrase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
exosome complex exonuclease RRP44, transcript variant X2
exosome complex exonuclease RRP44, transcript variant X3
exosome complex exonuclease RRP44, transcript variant X4
exosome complex exonuclease RRP44, transcript variant X1
exosome complex exonuclease RRP44 isoform X2
exosome complex exonuclease RRP44 isoform X3
exosome complex exonuclease RRP44 isoform X4
exosome complex exonuclease RRP44 isoform X1
patched domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 48 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
bifunctional purine biosynthesis protein ATIC, transcript variant X4
bifunctional purine biosynthesis protein ATIC, transcript variant X3
bifunctional purine biosynthesis protein ATIC, transcript variant X2
bifunctional purine biosynthesis protein ATIC, transcript variant X1
bifunctional purine biosynthesis protein ATIC isoform X4
bifunctional purine biosynthesis protein ATIC isoform X3
bifunctional purine biosynthesis protein ATIC isoform X2
bifunctional purine biosynthesis protein ATIC isoform X1
trypsin, alkaline C-like; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001320025.1
annotated by transcript or proteomic data
The RefSeq transcript has 21 substitutions, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: BestRefSeq.
COORDINATES: ab initio prediction:SignalP:4.0
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
insulin-related peptide 2, transcript variant X1
insulin-related peptide 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X3
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X1
guanine nucleotide-binding protein G(q) subunit alpha isoform X3
guanine nucleotide-binding protein G(q) subunit alpha isoform X1
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X2
guanine nucleotide-binding protein G(q) subunit alpha, transcript variant X5
guanine nucleotide-binding protein G(q) subunit alpha isoform X5
fatty-acid amide hydrolase 2-B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
fatty-acid amide hydrolase 2-B, transcript variant X2
fatty-acid amide hydrolase 2-B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
fatty-acid amide hydrolase 2-B isoform X1
fatty-acid amide hydrolase 2-B isoform X2
zinc finger MIZ domain-containing protein 1, transcript variant X1
zinc finger MIZ domain-containing protein 1, transcript variant X2
zinc finger MIZ domain-containing protein 1 isoform X1
zinc finger MIZ domain-containing protein 1 isoform X2
uncharacterized LOC105392014, transcript variant X1
uncharacterized LOC105392014, transcript variant X3
uncharacterized LOC105392014, transcript variant X2
uncharacterized protein LOC105392014 isoform X1
uncharacterized LOC105392014, transcript variant X4
uncharacterized protein LOC105392014 isoform X2
disks large homolog 2, transcript variant X1
disks large homolog 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytochrome b5-related protein, transcript variant X1
cytochrome b5-related protein, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X3
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X3
U-scoloptoxin(05)-Sm1a, transcript variant X2
U-scoloptoxin(05)-Sm1a, transcript variant X1
uncharacterized protein LOC105382284 isoform X2
uncharacterized LOC105382283, transcript variant X4
uncharacterized LOC105382283, transcript variant X3
uncharacterized LOC105382283, transcript variant X2
uncharacterized LOC105382283, transcript variant X1
uncharacterized protein LOC105382283 isoform X1
uncharacterized protein LOC105382283 isoform X2
uncharacterized protein LOC105382283 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor isoform X2
ras-related and estrogen-regulated growth inhibitor isoform X1
ras-related and estrogen-regulated growth inhibitor-like protein
major facilitator superfamily domain-containing protein 9
V-type proton ATPase 116 kDa subunit a 1, transcript variant X2
V-type proton ATPase 116 kDa subunit a 1, transcript variant X1
V-type proton ATPase 116 kDa subunit a 1, transcript variant X3
V-type proton ATPase 116 kDa subunit a 1 isoform X2
V-type proton ATPase 116 kDa subunit a 1 isoform X1
V-type proton ATPase 116 kDa subunit a 1 isoform X3
V-type proton ATPase 116 kDa subunit a 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
V-type proton ATPase 116 kDa subunit a 1 isoform X4
heat shock 70 kDa protein cognate 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001305515.1
The RefSeq transcript has 15 substitutions, 1 non-frameshifting indel and aligns at 98% coverage compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC105383335, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC105383335 isoform X1
uncharacterized LOC105383335, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC105383335 isoform X2
multiple epidermal growth factor-like domains protein 10
uncharacterized LOC105383305, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC105383305, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC105383305, transcript variant X3
uncharacterized LOC105383305, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized protein LOC105383305 isoform X1
uncharacterized protein LOC105383305 isoform X2
uncharacterized protein LOC105383305 isoform X3
uncharacterized protein LOC105383305 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
von Willebrand factor D and EGF domain-containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC105383303 isoform X3
uncharacterized protein LOC105383303 isoform X2
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
repetitive proline-rich cell wall protein 2
angiotensin-converting enzyme, transcript variant X2
angiotensin-converting enzyme, transcript variant X1
angiotensin-converting enzyme, transcript variant X3
angiotensin-converting enzyme, transcript variant X4
angiotensin-converting enzyme isoform X2
angiotensin-converting enzyme isoform X1
angiotensin-converting enzyme isoform X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
centaurin-gamma-1A, transcript variant X1
centaurin-gamma-1A, transcript variant X2
centaurin-gamma-1A, transcript variant X3
uncharacterized LOC119691084, transcript variant X1
uncharacterized LOC119691084, transcript variant X2
uncharacterized LOC119691084, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC119691084, transcript variant X3
uncharacterized protein LOC119691084 isoform X1
uncharacterized protein LOC119691084 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
cGMP-specific 3',5'-cyclic phosphodiesterase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
acid sphingomyelinase-like phosphodiesterase 3a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X3
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X1
calcium-binding mitochondrial carrier protein Aralar1 isoform X1
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X2
calcium-binding mitochondrial carrier protein Aralar1 isoform X2
calcium-binding mitochondrial carrier protein Aralar1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
40S ribosomal protein S14; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001309148.1
The RefSeq transcript has 5 substitutions, 1 non-frameshifting indel and aligns at 96% coverage compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
cytosolic carboxypeptidase-like protein 5
uncharacterized LOC105380325, transcript variant X1
uncharacterized LOC105380325, transcript variant X3
uncharacterized LOC105380325, transcript variant X2
uncharacterized protein LOC105380325 isoform X1
uncharacterized protein LOC105380325 isoform X3
uncharacterized protein LOC105380325 isoform X2
uncharacterized LOC105394567, transcript variant X1
uncharacterized LOC105394567, transcript variant X2
uncharacterized LOC105394567, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ribonuclease P protein subunit p30, transcript variant X2
ribonuclease P protein subunit p30, transcript variant X1
uncharacterized LOC105382868, transcript variant X5
uncharacterized LOC105382868, transcript variant X4
uncharacterized LOC105382868, transcript variant X2
uncharacterized LOC105382868, transcript variant X3
uncharacterized LOC105382868, transcript variant X1
uncharacterized LOC105382868, transcript variant X6
uncharacterized protein LOC105382868 isoform X4
uncharacterized protein LOC105382868 isoform X2
uncharacterized protein LOC105382868 isoform X3
uncharacterized protein LOC105382868 isoform X5
uncharacterized protein LOC105382868 isoform X1
uncharacterized protein LOC105382868 isoform X6
uncharacterized LOC105382868, transcript variant X7
uncharacterized LOC105382868, transcript variant X8
uncharacterized protein LOC105382868 isoform X7
CDGSH iron-sulfur domain-containing protein 2 homolog
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial
SH3 domain-containing kinase-binding protein 1
leucine-rich melanocyte differentiation-associated protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 85 samples with support for all annotated introns
leucine-rich melanocyte differentiation-associated protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
leucine-rich melanocyte differentiation-associated protein isoform X2
leucine-rich melanocyte differentiation-associated protein isoform X1
uncharacterized LOC125489011, transcript variant X1
uncharacterized LOC125489011, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105392586, transcript variant X2
uncharacterized LOC105392586, transcript variant X1
uncharacterized protein LOC105392586 isoform X1
uncharacterized protein LOC105392586 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 85 samples with support for all annotated introns
set1/Ash2 histone methyltransferase complex subunit ASH2, transcript variant X1
set1/Ash2 histone methyltransferase complex subunit ASH2, transcript variant X2
set1/Ash2 histone methyltransferase complex subunit ASH2, transcript variant X3
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X3
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X2
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1
2-acylglycerol O-acyltransferase 2-A, transcript variant X2
2-acylglycerol O-acyltransferase 2-A isoform X2
2-acylglycerol O-acyltransferase 2-A, transcript variant X1
2-acylglycerol O-acyltransferase 2-A isoform X1
uncharacterized LOC105392584, transcript variant X2
uncharacterized LOC105392584, transcript variant X4
uncharacterized LOC105392584, transcript variant X3
uncharacterized LOC105392584, transcript variant X1
uncharacterized LOC105392584, transcript variant X6
uncharacterized LOC105392584, transcript variant X5
uncharacterized protein LOC105392584 isoform X2
uncharacterized protein LOC105392584 isoform X6
uncharacterized protein LOC105392584 isoform X5
uncharacterized protein LOC105392584 isoform X4
uncharacterized protein LOC105392584 isoform X3
uncharacterized protein LOC105392584 isoform X1
uncharacterized LOC105392584, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC105392584 isoform X7
uncharacterized LOC105392584, transcript variant X8
uncharacterized protein LOC105392584 isoform X8
myosin heavy chain 95F, transcript variant X8
myosin heavy chain 95F, transcript variant X7
myosin heavy chain 95F, transcript variant X5
myosin heavy chain 95F, transcript variant X1
myosin heavy chain 95F, transcript variant X9
myosin heavy chain 95F, transcript variant X2
myosin heavy chain 95F, transcript variant X10
myosin heavy chain 95F, transcript variant X3
myosin heavy chain 95F, transcript variant X6
myosin heavy chain 95F, transcript variant X4
RNA-binding motif protein, X-linked 2, transcript variant X1
RNA-binding motif protein, X-linked 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
protein ST7 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein ST7 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC119694389
circadian clock-controlled protein daywake
uncharacterized protein LOC105392563 isoform X1
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
meiosis-specific nuclear structural protein 1
myc box-dependent-interacting protein 1, transcript variant X2
myc box-dependent-interacting protein 1, transcript variant X3
myc box-dependent-interacting protein 1, transcript variant X1
myc box-dependent-interacting protein 1 isoform X1
myc box-dependent-interacting protein 1 isoform X2
myc box-dependent-interacting protein 1 isoform X3
fatty-acid amide hydrolase 2-B, transcript variant X4
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial
terminal nucleotidyltransferase 5C, transcript variant X1
terminal nucleotidyltransferase 5C, transcript variant X2
terminal nucleotidyltransferase 5C, transcript variant X3
terminal nucleotidyltransferase 5C isoform X1
terminal nucleotidyltransferase 5C, transcript variant X4
terminal nucleotidyltransferase 5C isoform X2
protein GDAP2 homolog, transcript variant X1
protein GDAP2 homolog, transcript variant X3
protein GDAP2 homolog, transcript variant X2
glycosylphosphatidylinositol anchor biosynthesis protein 11
5-aminolevulinate synthase, non-specific, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 79 samples with support for all annotated introns
vacuolar protein sorting-associated protein 51 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 181, transcript variant X2
transmembrane protein 181, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
membrane alanyl aminopeptidase-like; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
membrane alanyl aminopeptidase-like, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001305517.1
The RefSeq transcript has 50 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
membrane alanyl aminopeptidase-like isoform X1
similar to AA sequence (same species):RefSeq:NP_001292446.1
The RefSeq protein has 15 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
membrane alanyl aminopeptidase-like precursor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
katanin p60 ATPase-containing subunit A1, transcript variant X2
katanin p60 ATPase-containing subunit A1, transcript variant X1
katanin p60 ATPase-containing subunit A1, transcript variant X4
katanin p60 ATPase-containing subunit A1, transcript variant X3
katanin p60 ATPase-containing subunit A1 isoform X2
katanin p60 ATPase-containing subunit A1 isoform X1
katanin p60 ATPase-containing subunit A1 isoform X4
katanin p60 ATPase-containing subunit A1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66% coverage of the annotated genomic feature by RNAseq alignments
sphingosine-1-phosphate lyase, transcript variant X3
sphingosine-1-phosphate lyase, transcript variant X1
sphingosine-1-phosphate lyase, transcript variant X2
nuclear envelope integral membrane protein 1a
NEDD8-activating enzyme E1 catalytic subunit
uncharacterized LOC105384866, transcript variant X2
uncharacterized LOC105384866, transcript variant X1
uncharacterized LOC105384866, transcript variant X3
uncharacterized protein LOC105384866 isoform X1
uncharacterized protein LOC105384866 isoform X2
ATP synthase subunit beta, mitochondrial
ubiquinol-cytochrome-c reductase complex assembly factor 1
max-like protein X, transcript variant X2
max-like protein X, transcript variant X1
uncharacterized LOC105383999, transcript variant X2
uncharacterized LOC105383999, transcript variant X3
uncharacterized LOC105383999, transcript variant X1
acetylcholinesterase, transcript variant X1
acetylcholinesterase, transcript variant X2
corticotropin-releasing factor-binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
probable aldehyde oxidase gad-3, transcript variant X2
probable aldehyde oxidase gad-3, transcript variant X1
uncharacterized LOC105383033, transcript variant X2
uncharacterized LOC105383033, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
signal peptidase complex catalytic subunit SEC11A
interleukin-1 receptor-associated kinase 4
MICOS complex subunit MIC13 homolog QIL1
ATP-dependent (S)-NAD(P)H-hydrate dehydratase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 85 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 5
60S ribosomal protein L24; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001309135.1
The RefSeq transcript has 10 substitutions, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001296064.1
The RefSeq protein has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (Q6F444.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
importin subunit alpha-7, transcript variant X1
importin subunit alpha-7, transcript variant X2
importin subunit alpha-7, transcript variant X3
importin subunit alpha-7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105387937, transcript variant X1
uncharacterized protein LOC105387937 isoform X1
uncharacterized LOC105387937, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized protein LOC105387937 isoform X2
uncharacterized LOC105387937, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC105387937, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
uncharacterized protein LOC105387937 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
U3 small nucleolar RNA-associated protein 18 homolog
dnaJ homolog subfamily A member 1, transcript variant X1
dnaJ homolog subfamily A member 1, transcript variant X2
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, transcript variant X1
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, transcript variant X4
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, transcript variant X2
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, transcript variant X3
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic isoform X4
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic isoform X1
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic isoform X2
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic isoform X3
methionyl-tRNA formyltransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 211 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC105391098, transcript variant X4
uncharacterized LOC105391098, transcript variant X3
uncharacterized LOC105391098, transcript variant X2
uncharacterized LOC105391098, transcript variant X1
uncharacterized protein LOC105391098 isoform X2
uncharacterized protein LOC105391098 isoform X1
uncharacterized LOC119693679, transcript variant X1
uncharacterized LOC119693679, transcript variant X2
uncharacterized LOC119693679, transcript variant X3
uncharacterized LOC119693679, transcript variant X4
39S ribosomal protein L32, mitochondrial
all trans-polyprenyl-diphosphate synthase PDSS1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 78% coverage of the annotated genomic feature by RNAseq alignments
transcription factor SPT20 homolog, transcript variant X2
transcription factor SPT20 homolog, transcript variant X1
transcription factor SPT20 homolog isoform X1
transcription factor SPT20 homolog isoform X2
coiled-coil domain-containing protein 12
F-box only protein 28, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
F-box only protein 28, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
F-box only protein 28, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 84 samples with support for all annotated introns
molybdenum cofactor sulfurase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
molybdenum cofactor sulfurase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
molybdenum cofactor sulfurase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
uncharacterized LOC125488961, transcript variant X1
uncharacterized LOC125488961, transcript variant X2
glutathione synthetase; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001309054.2
The RefSeq transcript has 36 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC105390596, transcript variant X2
uncharacterized LOC105390596, transcript variant X1
uncharacterized protein LOC105390596 isoform X1
uncharacterized protein LOC105390596 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
S-adenosylmethionine synthase, transcript variant X2
S-adenosylmethionine synthase, transcript variant X1
S-adenosylmethionine synthase isoform X2
S-adenosylmethionine synthase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
origin recognition complex subunit 2, transcript variant X2
origin recognition complex subunit 2, transcript variant X1
origin recognition complex subunit 2 isoform X2
origin recognition complex subunit 2 isoform X1
acidic leucine-rich nuclear phosphoprotein 32 family member A, transcript variant X1
acidic leucine-rich nuclear phosphoprotein 32 family member A, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X2
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
formin-like protein 16, transcript variant X2
formin-like protein 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 64% coverage of the annotated genomic feature by RNAseq alignments
glutamate-gated chloride channel, transcript variant X24
glutamate-gated chloride channel, transcript variant X2
glutamate-gated chloride channel, transcript variant X26
glutamate-gated chloride channel, transcript variant X25
glutamate-gated chloride channel, transcript variant X15
glutamate-gated chloride channel, transcript variant X6
glutamate-gated chloride channel, transcript variant X27
glutamate-gated chloride channel, transcript variant X3
glutamate-gated chloride channel, transcript variant X10
glutamate-gated chloride channel, transcript variant X9
glutamate-gated chloride channel, transcript variant X4
glutamate-gated chloride channel, transcript variant X1
glutamate-gated chloride channel, transcript variant X20
glutamate-gated chloride channel, transcript variant X16
glutamate-gated chloride channel, transcript variant X8
glutamate-gated chloride channel, transcript variant X18
glutamate-gated chloride channel, transcript variant X14
glutamate-gated chloride channel, transcript variant X13
glutamate-gated chloride channel, transcript variant X11
glutamate-gated chloride channel, transcript variant X12
glutamate-gated chloride channel, transcript variant X5
glutamate-gated chloride channel, transcript variant X7
glutamate-gated chloride channel, transcript variant X19
glutamate-gated chloride channel, transcript variant X23
glutamate-gated chloride channel, transcript variant X17
glutamate-gated chloride channel, transcript variant X22
glutamate-gated chloride channel, transcript variant X21
glutamate-gated chloride channel isoform X19
glutamate-gated chloride channel isoform X23
glutamate-gated chloride channel isoform X26
glutamate-gated chloride channel isoform X20
glutamate-gated chloride channel isoform X16
glutamate-gated chloride channel isoform X8
glutamate-gated chloride channel isoform X17
glutamate-gated chloride channel isoform X22
glutamate-gated chloride channel isoform X25
glutamate-gated chloride channel isoform X18
glutamate-gated chloride channel isoform X24
glutamate-gated chloride channel isoform X15
glutamate-gated chloride channel isoform X6
glutamate-gated chloride channel isoform X21
glutamate-gated chloride channel isoform X14
glutamate-gated chloride channel isoform X13
glutamate-gated chloride channel isoform X27
glutamate-gated chloride channel isoform X3
glutamate-gated chloride channel isoform X11
glutamate-gated chloride channel isoform X12
glutamate-gated chloride channel isoform X5
glutamate-gated chloride channel isoform X10
glutamate-gated chloride channel isoform X9
glutamate-gated chloride channel isoform X7
glutamate-gated chloride channel isoform X4
glutamate-gated chloride channel isoform X2
glutamate-gated chloride channel isoform X1
poly(rC)-binding protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
poly(rC)-binding protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
poly(rC)-binding protein 3, transcript variant X2
poly(rC)-binding protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
poly(rC)-binding protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
poly(rC)-binding protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins